title: Scabies.
authors.affiliation: Blenheim House, Leeds, United Kingdom.
authors.forename: Paul
authors.initials: P
authors.lastname: Johnstone
authors.affiliation: University of Sheffield, Sheffield, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Stong
mesh_terms: D000818:Animals; D000977:Antiparasitic Agents / Q000008:administration & dosage / Q000009:adverse effects; D004333:Drug Administration Routes; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000009:adverse effects; D026023:Permethrin / Q000008:administration & dosage / Q000009:adverse effects; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors; D012520:Sarcoptes scabiei / Q000187:drug effects / Q000472:pathogenicity / Q000502:physiology; D012532:Scabies / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D014052:Toluidines / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000977:Antiparasitic Agents; D004791:Enzyme Inhibitors; D014052:Toluidines; D026023:Permethrin; D007559:Ivermectin; C005553:crotamiton